| AMARIN CORP.ADR NEW 2025 |
| USA |
| Gesundheit |
| US0231114044 / A41557 |
| EH3 (Frankfurt) / AMRN (NASDAQ) |
| FRA:EH3, ETR:EH3, EH3:GR, NASDAQ:AMRN |
| - |
| https://www.amarincorp.co.. |
|
Amarin Corporation plc - American Depositary Receipt represents shares in Amarin Corporation plc, a pharmaceutical company focused on the commercialization and development of therapeutics for cardiovascular health in the United States, Europe, and in..
>Volltext.. |
| 277.32 Mio. EUR |
| 16.88 Mio. EUR |
| 187.04 Mio. EUR |
| -1.85 Mio. EUR |
| -29.04 Mio. EUR |
| -1.4 EUR |
| 4.81 Mio. EUR |
| 113.04 Mio. EUR |
| 22.07 Mio. EUR |
| 1.71 |
| 1.4% |
| 61.59% |
| - |
| - |
| - |
| - |
| AMARIN |
| 17.06.26 |
|